Contenido en Inglés English |   imprimir el articulo Imprimir

Publicaciones desde 2009 (con filiación UCA)

TRABAJOS ORIGINALES EN REVISTAS DE CIRCULACIÓN INTERNACIONAL

2017

  • Worsening of memory deficit induced by energy-dense diet in a rat model of early-Alzheimer's disease is associated to neurotoxic Aβ species and independent of neuroinflammation. P. V. Martino Adami, P. Galeano, M. L. Wallinger, C. Quijano, A. Rabossi, E.S. Pagano, N. Olivar , C. Reyes Toso, D. Cardinali, L.I. Brusco, S. Do Carmo, R. Radi , G. Gevorkian, E. M. Castaño, A.C. Cuello, L. Morelli. Biochimica et Biophysica Acta 1863 (2017) 731–743
  • The influence of intermittent fasting on the circadian pattern of melatonin while controlling for caloric intake, energy expenditure, light exposure, and sleep schedules: a preliminary report. A. S. Almeneessier, A. S. Bahammam, M. M. Sharif, S. A. Bahammam, S. Z. Nashwan, S. R. Pandi-Perumal, D. P. Cardinali, M. Alzoghaibi. Annals of Thoracic Medicine, en prensa

2016

  • Comparative analysis of actigraphy performance in healthy young subjects. G. J. Bellone, S. A. Plano, D. P. Cardinali, D. Pérez Chada, D. E. Vigo, D. A. Golombek. Sleep Science, 9 (2016) 272–279

2015

  • Melatonin counteracts changes in hypothalamic gene expression of signals regulating feeding behavior in high-fat fed rats. M.J. Ríos-Lugo, V. Jiménez-Ortega, P. Cano-Barquilla, P. Fernández Mateos, E. J. Spinedi, D. P. Cardinali, A. I. Esquifino.Hormone Molecular Biology and ClinicalInvestigation2015 21(3):175-183
  • Sleep and neighborhood safety in a Latin American Country. G. Simonelli, S.R. Patel, S. Rodríguez-Espínola, D. Pérez-Chada, A. Salvia, D.P. Cardinali, D.E. Vigo. Sleep Health, 1: 98–103; 2015.

2014

  • Per3 length polymorphism in patients with type 2 diabetes mellitus. R. Karthikeyan, G. Marimuthu, M. Sooriyakumar, A. S. BaHammam, D. W. Spence, S. R. Pandi-Perumal, G. M. Brown, D. P. Cardinali.Hormone Molecular Biology and Clinical Investigation, 18 (3) 145-149, 2014.
  • Sleep habits, daytime sleepiness and working conditions in short-distance bus drivers. J. J. Diez, D. E. Vigo, D. P. Cardinali, D. Pérez Chada. International Journal of WorkplaceHealth Management7 (4): 202-212; 2014
  • Melatonin normalizes clinical and biochemical parameters of mild inflammation in diet-induced metabolic syndrome in rats. P. Cano-Barquilla, E. S. Pagano, V. Jiménez-Ortega, P. Fernández-Mateos, A. I. Esquifino, D. P. Cardinali. Journal of Pineal Research, 57:280–290, 2014
  • Effects of different “relaxing” music styles on the autonomic nervous system. S. Pérez-Lloret, J. Diez, M. N. Domé, A. AlvarezDelvenne, N. Braidot, D. P. Cardinali, D. E. Vigo. Noise&Health, 16:279-284; 2014.
  • School characteristics, child work, and other daily activities as sleep deficit predictors in adolescents from households with unsatisfied basic needs. D.E. Vigo, G. Simonelli, I. Tuñón, D. Pérez Chada, D.P. Cardinali, D. Golombek. Mind, Brain, and Education, 2014, 8 (4), 175-181.
  • Association of Per3 length polymorphism with bipolar I disorder and schizophrenia. R. Karthikeyan, G. Marimuthu, C. Ramasubramanian, G. Arunachal, A. S. BaHammam, D. W. Spence, D.P. Cardinali, G.M. Brown, S.R. Pandi-Perumal. Neuropsychiatric Disease and Treatment, 2014, 10: 2025-2030.
  • Assessment of arterial stiffness by 24-hour ambulatory blood pressure monitoring in nocturnal hypertensive or normotensive subjects. L. Drucaroff , A. Ramirez, A. Sanchez, DP Cardinali, S. Perez-Lloret. Integrative Medicine International 2014, 1:130–135
  • Anxiety, anger, salivary cortisol and cardiac autonomic activity in palliative care professionals with and without mind-body training experience: results from a pilot study. Iglesias, SL; Azzara, S; Granchetti, H; Lagomarsino, E; Vigo DE. European Journal of Integrative Medicine, 2014 6(1): 98-103

2013

  • Sleep and quality of life in urban poverty: the impact of a slum-housing upgrading program. Simonelli G, Leanza Y, Boilard A, Hyland M, Augustinavicius J, Cardinali DP, Pérez Chada D, Vigo DE. Sleep, 2013 nov 1, 36: 1669-1676.
  • Circadian rhythm of autonomic cardiovascular control during Mars500 simulated mission to Mars. Vigo DE, Tuerlinckx F, Ogrinz B, Wan L, Simonelli G, Bersenev E, Van den Bergh O, Aubert A. Aviation, Space and Environmental Medicine, 2013 oct 84: 1023-1028 (download pdf).
  • Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in rats. D. P. Cardinali, P.A. Scacchi Bernasconi, R. Reynoso, C.F. Reyes Toso, P. Scacchi. International Journal of Molecular Sciences, 14: 2502 - 2514. 2013.
  • Don’t worry, be mindful: Effects of induced worry and mindfulness on respiratory variability in a non-anxious population. Vlemincx, E., D. Vigo, DE. Vansteenwegen, O. Van den Bergh, I. Van Diest. International Journal of Psychophysiology 2013 Feb;87(2):147-51.

2012

  • Melatonin supplementation decreases prolactin synthesis and release in rat adenohypophysis. Correlation with anterior pituitary redox state and circadian clock mechanisms.V. Jiménez-Ortega, P. Cano Barquilla, E.S. Pagano, P. Fernández-Mateos, A.I. Esquifino, D.P. Cardinali.Chronobiology International29 (8): 1021-1035. 2012. (download pdf)
  • Cadmium as an endocrine disruptor. Correlation with anterior pituitary redox and circadian clock mechanisms and prevention by melatonin.V. Jiménez-Ortega, P. Cano Barquilla, P. Fernández-Mateos, D.P. Cardinali, A.I. Esquifino.Free Radical Biology & Medicine53: 2287–2297; 2012.
  • Different effects by sex on hypothalamic-pituitary axis of prepubertal offspring rats produced by in utero and lactational exposure to di-(2-ethylhexyl) phthalate (DEHP). Carbone S, Samaniego YA, Cutrera R, Reynoso R, Cardoso N, Scacchi P, Moguilevsky JA, Ponzo OJ. Neurotoxicology. 2012 Jan;33(1):78-84.
  • Discontinuous vs. continuous drinking of ethanol in peripubertal rats: effect on 24-hour pattern of hypophyseal-gonadal axis activity and anterior pituitary oxidative stress. P. Fernández-Mateos, V. Jiménez-Ortega, P. Cano Barquilla, D.P. Cardinali, A.I. Esquifino.Neuroendocrinology, 96(3): 194-203; 2012 DOI: 10.1159/000334963. (download pdf)
  • A multi-step pathway connecting short sleep duration to daytime somnolence, reduced attention and poor academic performance. An exploratory cross-sectional study in teenagers. Pérez Lloret S, Videla AJ, Richaudeau A, Vigo DE, Rossi M, Cardinali DP, Pérez Chada D. Journal of Clinical Sleep Medicince 9(5): 469-73; 2012.
  • Therapeutic application of melatonin in mild cognitive impairment. D.P. Cardinali, D.E. Vigo, N. Olivar, M.F. Vidal, A.M. Furio, L.I. Brusco. American Journal of Neurodegenerative Disease1(3):280-291; 2012. (download pdf)
  • Sleep-wake differences in heart rate variability during a 105-day simulated mission to Mars. DE Vigo, B Ogrinz, L. Wan, E. Bersenev, F. Tuerlinckx, O Van Den Bergh, A.E. Aubert. Aviat Space Environ Med. 2012 Feb;83(2):125-30. (download pdf)
  • Pregabalin beneficial effects on sleep quality or health-related quality of life are poorly correlated with reduction on pain intensity after an 8-week treatment course. S. Perez-Lloret., G.M. Rojas, M.C. Menoni , G. Ruiz, C. Velásquez, H. Rodriguez, M.V. Rey, D.P. Cardinali for the PGB Study Team. Clinical Neuropharmacology 35(1):21-24, 2012. (download pdf)
  • Cardiac autonomic activity predicts dominance in verbal over spatial reasoning tasks: results from a preliminary study. J. I. Solernó, D. Pérez Chada, S. M. Guinjoan, S. Pérez Lloret, A. Hedderwick, M. F. Vidal, D. P. Cardinali, D. E. Vigo. Autonomic Neuroscience: Basic and Clinical 167(1-2):78-80, 2012. (download pdf)
  • IL-17 and IFN-γ expression in lymphocytes from patients with active tuberculosis correlates with the severity of the disease. Jurado, J.O., Pasquinelli, V., Alvarez, I.B., Peña, D., Rovetta, A.I., Tateosian, N.L., Romeo, H.E., Musella, R.M., Palmero, D., Chuluyán, H.E., García, V.E. (2012). Journal of Leucocyte Biology 91: 991-1002.

2011

  • Autonomic nervous system activation during social cognition tasks in patients with schizophrenia and their unaffected relatives. O.I. Jáuregui, E.Y. Costanzo, D de Achával, MF Villarreal, E. Chu, M.C. Mora, D.E. Vigo, M.N. Castro, R.C. Leiguarda, K.J. Bär, S.M. Guinjoan. Cogn Behav Neurol. 2011 Dec;24(4):194-203.
  • Cardiovascular autonomic adaptation to long-term confinement during a 105-day simulated Mars mission. Wan L., Ogrinz B., Vigo DE., Bersenev E., Tuerlinckx F., van den Bergh O., & Aubert A. Aviation, Space and Environmental Medicine. 2011Jul;82(7):711-6.(download pdf)
  • Sleep habits, alertness, cortisol levels and cardiac autonomic activity in short distance bus drivers: differences between morning and afternoon shifts. J. J. Diez, D.E. Vigo, S. Pérez Lloret, S. Rigters, N. Rolé, D.P. Cardinali, D. Pérez Chada. Journal of Occupational and Environmental Medicine 53(7); 806-811; 2011. (download pdf)
  • Higher autonomic activation predicts better performance at Iowa Gambling Task. L J. Drucaroff, . Kievit, S.M. Guinjoan, E. Roldán Gerschcovich, R. Leiguarda, D,P. Cardinali,D.E. Vigo. Cognitive and Behavioral Neurology. 2011 Jun;24(2):93-8. (download pdf)
  • Non-motor symptoms groups in Parkinson’s disease patients. Results of a pilot, exploratory study. S. Perez Lloret, M. Rossi, M. Merello, O. Rascol, D. P. Cardinali. Parkinson's Disease, Vol 2011, Article ID 473579, 5 pages, 2011, doi:10.4061/2011/473579.(download pdf)
  • Measurement of melatonin in body fluids: standards, protocols, and procedures. E.A. de Almeida, P. Di Mascio, T. Harumi, D.W. Spence, A. Moscovitch, R. Hardeland, D.P. Cardinali, G.M. Brown, S.R. Pandi-Perumal. Child´s Nervous System. 27(6): 879-891; 2011. (download pdf)
  • Cadmium-induced disruption in 24-h expression of clock and redox enzyme genes in rat medial basal hypothalamus: Prevention by melatonin. V. Jiménez-Ortega , P. Cano-Barquilla, P. A. Scacchi, D. P. Cardinali, A. I. Esquifino. Frontiers in Neurology (Sleep and Chronobiology) 2011 Mar 6;2:13.(acceso abierto). (download pdf)
  • Probable gamma-aminobutyric acid involvement in bisphenol A effect at the hypothalamic level in adult male rats. Cardoso N, Pandolfi M, Lavalle J, Carbone S, Ponzo O, Scacchi P, Reynoso R. J Physiol Biochem. 2011 Dec;67(4):559-67.
  • Expression of erythroblastic leukemia viral oncogene homolog (erbBS) mRNAs and possible splice variants in 3T3-L1 preadipocytes. Pagano E, Fontana V, Calvo JC. Mol Med Report. 2011 4(5):955-61.
  • Melatonin and the metabolic syndrome. Physiopathologic and therapeutical implications. D. P. Cardinali, P.Cano, V. Jiménez-Ortega, A. I. Esquifino. Neuroendocrinology 93(3):133-142, 2011. (download pdf)
  • Continuous vs. discontinuous drinking of an ethanol liquid diet in peripubertal rats: Effect on 24-hour variation of lymph node and splenic mitogenic responses and lymphocyte subset populations. V. Jiménez-Ortega, M.P. Fernández-Mateos, P. Cano-Barquilla, D.P. Cardinali, A. I. Esquifino. Alcohol 45:183-192; 2011. (download pdf)

2010

  • Clinical aspects of melatonin intervention in Alzheimer’s disease progression. D. P. Cardinali, A. M. Furio, L. I. Brusco. Current Neuropharmacology 8 (3): 218-227; 2010. (download pdf)
  • Heart rate nonlinear dynamics during sudden hypoxia at 8,230 m simulated altitude. D.E. Vigo, S. Pérez Lloret, A.J. Videla, D. Pérez Chada, H.M. Hünicken, J. Mercuri, R. Romero, L. Nicola Siri, D.P. Cardinali. Wilderness & Environmental Medicine, 21, 4–10; 2010.(download pdf)
  • In vitro effect of octyl - methoxycinnamate (OMC) on the release of Gn-RH and amino acid neurotransmitters by hypothalamus of adult rats. 6: Carbone S, Szwarcfarb B, Reynoso R, Ponzo OJ, Cardoso N, Ale E, Moguilevsky JA, Scacchi P. Exp Clin Endocrinol Diabetes. 2010 May;118(5):298-303.
  • Impact of gestational and lactational phthalate exposure on hypothalamic content of amino acid neurotransmitters and FSH secretion in peripubertal male rats. 5: Carbone S, Szwarcfarb B, Ponzo O, Reynoso R, Cardoso N, Deguiz L, Moguilevsky JA, Scacchi P. Neurotoxicology. 2010 Dec;31(6):747-51.
  • Reproductive axis response to repeated lipopolysaccharide administration in peripubertal female rats. Cardoso N, Arias P, Szwarcfarb B, Ponzo O, Carbone S, Moguilevsky J, Scacchi P, Reynoso RM. Physiol Biochem. 2010 Sep;66(3):237-44.
  • Evidence to suggest glutamic acid involvement in Bisphenol A effect at the hypothalamic level in prepubertal male rats Cardoso N, Pandolfi M, Ponzo O, Carbone S, Szwarcfarb B, Scacchi P, Reynoso R. . Neuro Endocrinol Lett. 2010;31(4):512-6.
  • Melatonin effect on plasma adiponectin, leptin, insulin, glucose, triglycerides and cholesterol in normal and high fat-fed rats. M.J. Ríos-Lugo, P. Cano, V. Jiménez-Ortega, M. P. Fernández-Mateos, P. A. Scacchi, D. P. Cardinali, A. I. Esquifino. Journal of Pineal Research 49:342–348; 2010. (download pdf)
  • Effect of cadmium on 24-hour pattern in expression of redox enzyme and clock genes in medial basal hypothalamus. V. Jiménez-Ortega, D.P. Cardinali, M.P. Fernández-Mateos , M J Ríos-Lugo, P.A. Scacchi, A.I. Esquifino. Biometals 23 (2):327–337; 2010. (download pdf)
  • Effect of a high-fat diet on 24-hour pattern in expression of prolactin and redox pathway enzymes in the rat adenohypophysis. P. Cano, D.P. Cardinali, V. Jiménez-Ortega, M.J. Ríos-Lugo, P.A. Scacchi, A. I. Esquifino. The Open Obesity Journal, 2: 1-9, 2010. (download pdf)

2009

  • 24-Hour variation in gene expression of redox pathway enzymes in rat hypothalamus: effect of melatonin treatment. V. Jiménez-Ortega, P. Cano, D. P. Cardinali, A. I. Esquifino. Redox Report 14 (3): 132-138;2009.



TRABAJOS DE REVISIÓN EN REVISTAS DE CIRCULACIÓN INTERNACIONAL

2017

  • Preface. E. Spinedi, D.P. Cardinali, J.J. Gagliardino Neuroendocrinology 2017;104(4):317-318
  • Inflammaging, metabolic syndrome and melatonin: a call for treatment studies. D.P. Cardinali, R Hardeland. Neuroendocrinology 104(4):382-397; 2017
  • Melatonin and human cardiovascular disease. S. R. Pandi-Perumal, A. S. BaHammam, N. I. Ojike, O. A. Akinseye, T. Kendzerska, K. Buttoo, P. S Dhandapany, G. M. Brown, D. P. Cardinali. Journal of Cardiovascular Pharmacology and Therapeutics, 22(2) 122-132, 2017

2016

  • New concepts in the neurophysiology of sleep and wakefulness. A. Garay, D. P. Cardinali. Physiological Mini Reviews, 9 (3) 26-36, 2016
  • Assessing the efficacy of melatonin to curtail benzodiazepine/ Z drug abuse. DP Cardinali, DA Golombek, RE Rosenstein, LI Brusco, DE Vigo. Pharmacological Research, 109: 12-23; 2016
  • Melatonin-induced oncostasis. Mechanisms and clinical relevance. D. Cardinali, G. Escames, D. Acuña-Castroviejo, F. Ortiz, B. Fernández-Gil, A Guerra Librero, S. García-López, Y. Shen, J. Florido. Integrative Oncology S1: 006. doi:10.4172/2329-6771.S1-006.

2015

  • Melatonin and brain inflammaging. R. Hardeland, D.P. Cardinali, G.M. Brown, S.R. Pandi-Perumal. Progress in Neurobiology 127–128 (2015) 46–63.
  • Some implications of melatonin use in chronopharmacology of insomnia. D.A. Golombek, S.R. Pandi-Perumal, G.M. Brown, D.P. Cardinali. European Journal of Pharmacology, 762 (2015) 42–48
  • Melatonina y consumo de benzodiacepinas: Un ejemplo de medicina traslacional. Cardinali D.P., Vigo D.E. La Prensa Médica Argentina 101, 278-282, 2015
  • A diez años de la primera encuesta sobre prevalencia de alteraciones del sueño en poblaciones urbanas de América Latina: ¿Cómo dormimos los argentinos?. Vigo, D.E., Cardinali D.P. La Prensa Médica Argentina 101, 266-277, 2015
  • Estudios básicos y clínicos sobre la melatonina como ejemplo de medicina traslacional. Cardinali D.P. Ciencia e Investigación Reseñas, 3, 22-35, 2015 ISSN 2314-3134

2014

  • Ghrelin and its interactions with growth hormone, leptin and orexins: Implications for the sleepewake cycle and metabolism. F. García-García, E. Juárez-Aguilar. J. Santiago-García. D. P. Cardinali. Sleep Medicine Reviews, 2014 18(1):89-97
  • Melatonin therapy in patients with Alzheimer's disease. D. P. Cardinali, D. E. Vigo, N. Olivar, M. F. Vidal, L. I. Brusco. Antioxidants 3, 245-277; 2014; doi:10.3390/antiox3020245
  • Should we listen to our clock to prevent type 2 diabetes mellitus? R. Karthikeyan, G. Marimuthu, D. W. Spence, S. R. Pandi-Perumal, A. S. BaHammam, G. M. Brown, D. P. Cardinali. Diabetes Research and Clinical Practice, 2014 106(2):182-90. http://dx.doi.org/10.1016/j.diabres.2014.07.029
  • Melatonin Therapy in Patients with Alzheimer’s Disease.Cardinali DP, Vigo DE, Olivar N, Vidal MF, Brusco LI. Antioxidants 2014, 3, 245-277. (download pdf)

2013

  • Ghrelin and its interactions with growth hormone, leptin and orexins: Implications for the sleep-wake cycle and metabolism. García-García F, Juárez-Aguilar E, Santiago-García J, Cardinali DP.Sleep Med Rev. 2013 Jun 28.
  • Emerging drugs for autonomic dysfunction in Parkinson's disease. Perez-Lloret S, Rey MV, Pavy-Le Traon A, Rascol O. Expert Opin Emerg Drugd 18(1): 39-53; 2013
  • Diagnosis and treatment of orthostatic hypotension in Parkinon's Disease. Perez-Lloret S, Rey VR, Pavy-Le Traon A, Rascol O. Int. J. Integr. Med, Vol 1, 27: 2013 (download pdf)
  • Orthostatic hypotension in Parkinson's disease. Perez-Lloret S, Rey MV, Pavy-Le Traon A, Rascol O. Neurodegen. Dis. Manage. 3(4): 363-377; 2013
  • Apomorphine for the treatment of refractory motor fluctuations in late stage Parkinson's disease: an old drug revisited. Perez-Lloret S. Eur. J. Neurol. 2013 feb 11
  • Ayurveda medicine for the treatment of Parkinson's disease. Perez Lloret S, Rey MV, Rascol O. Int. Intergrative Med, 2013, vol 1, 6: 2013(download pdf)
  • Sleep and circadian rhythm dysregulation in schizophrenia. J. M. Monti, A. S. BaHammam, S. R. Pandi-Perumal, V. Bromundt, D. W. Spence, D. P. Cardinali, G. M. Brown.Progress in Neuro-Psychopharmacology & Biological Psychiatry43:209–216; 2013
  • Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. S.R. Pandi-Perumal, A. S. BaHammam, G.M. Brown, D.W. Spence, V.K. Bharti, C. Kaur, R. Hardeland, D.P. Cardinali. Neurotoxicity Research 2013 Apr;23(3):267-300. (download pdf)

2012

  • Melatonin antioxidative defense: therapeutical implications for aging and neurodegenerative processes. S.R. Pandi-Perumal, A. S. BaHammam, G.M. Brown, D.W. Spence, V.K. Bharti, C. Kaur, R. Hardeland, D.P. Cardinali.Neurotoxicity Research, Early Online (2012) (download pdf)
  • New developments in the treatment of primary insomnia in elderly patients - Focus on prolonged release melatonin. D.P. Cardinali, M.F. Vidal, D.E. Vigo. ChronoPhysiology and Therapy, 2: 67–79; 2012. (download pdf)
  • Agomelatine: Its role in the management of major depressive disorder. D. P. Cardinali, M. F. Vidal, D. E. Vigo. Clinical Medicine Insights: Psychiatry 2012:4 1–23. (download pdf)
  • Melatonin and its analogs in insomnia and depression. D. P. Cardinali, V. Srinivasan, A. Brzezinski, G. M. Brown. Journal of Pineal Research 52(4):365-375, 2012. (download pdf)
  • Melatonin and mitochondrial dysfunction in the central nervous system.D.P. Cardinali, E.S. Pagano, P.A. Scacchi Bernasconi , R. Reynoso, P. Scacchi.Hormones and Behavior (2012) (download pdf)
  • Sleep and the immune system. D.P. Cardinali, A.I. Esquifino. Current Immunology Reviews, 8: 50-62; 2012. (download pdf)

2011

  • Sleep and circadian dysregulation in depressive illness. Pharmacological implications. D.P. Cardinali, S.R.. Pandi-Perumal, G.M. Brown. Clinical Neuropsychiatry 8 (6) 321-338, 2011. (download pdf)
  • Melatonin agonists in primary insomnia and depression-associated insomnia: Are they superior to sedative-hypnotics? V. Srinivasan, A. Brzezinski, S. R. Pandi-Perumal, D. W, Spence, D. P. Cardinali, Gregory M. Brown. Progress in Neuro-Psychopharmacology & Biological Psychiatry 35 (2011) 913–923. (download pdf)
  • Melatonin in Chagas´ disease. Possible therapeutic value. D. P. Cardinali, C. B. Álvarez. Medicina (Buenos Aires), 71(5):477-483; 2011. (download pdf)
  • Melatonin agonists for treatment of sleep and depressive disorders. V. Srinivasan, D.P. Cardinali, S.R. Pandi-Perumal, G. M. Brown. Journal of Experimental and Integrative Medicine 1(3):149-158; 2011. (download pdf)
  • Pharmacotherapy of insomnia with ramelteon: safety, efficacy and clinical applications. S.R. Pandi-Perumal, D.W. Spence, J.C. Verster, V. Srinivasan, G.M. Brown, D.P. Cardinali, R. Hardeland. Journal of Central Nervous System Disease 3: 51–65, 2011. (download pdf)
  • Therapeutic potential of melatonin and its analogs in Parkinson´s disease: Focus on sleep and neuroprotection. V. Srinivasan, D.P. Cardinali, U.S. Srinivasan, C. Kaur, G.M. Brown, D.W. Spence, R. Hardeland, S.R. Pandi-Perumal. Therapeutic Advances in Neurological Disorders 4: 297-317; 2011. (download pdf)
  • Melatonin and its agonist ramelteon in Alzheimer’s disease: possible therapeutic value. V. Srinivasan, C. Kaur, S. R. Pandi-Perumal, G. M. Brown, D. P. Cardinali. International Journal of Alzheimer’s Disease, vol. 2011, (download pdf)
  • The use of chronobiotics in the resynchronization of the sleep/wake cycle. Therapeutical application in the early phases of Alzheimer´s disease. D. P. Cardinali, A. M. Furio, L. I. Brusco. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery, 5 (2), 80-90, 2011. (download pdf)
  • Disrupted chronobiology of sleep and cytoprotection in obesity: possible therapeutic value of melatonin. D.P. Cardinali, E.S. Pagano, P.A. Scacchi Bernasconi, R. Reynoso, P. Scacchi. Neuroendocrinology Letters 32(5):588–606, 2011. (download pdf)
  • Melatonin –a pleiotropic, orchestrating regulator molecule. R. Hardeland, D. P. Cardinali, V. Srinivasan, D. W. Spence, G. M. Brown, S. R. Pandi-Perumal. Progress in Neurobiology 93, 350–384, 2011. (download pdf)

2010

  • Jet lag, circadian rhythm sleep disturbances and depression: the role of melatonin and its analogs. V. Srinivasan, J. Singh, S. R. Pandi-Perumal,D. W. Spence, G.M. Brown,, D.P. Cardinali. Advances in Therapy 27(11):796-813; 2010. (download pdf)
  • Chronophysiology of melatonin: therapeutical implications. D. P. Cardinali, P. A. Scacchi. The Open Neuroendocrinology Journal 3, 72-84; 2010. (download pdf)
  • Sleep, mood disorders and antidepressants: the melatonergic antidepressant agomelatine offers a new strategy for treatment. V Srinivasan, A. Brzezinski, D. W. Spence, S. R. Pandi-Perumal, R. Hardeland, G. M. Brown, D. P. Cardinali. Psychiatria Fennica 41:168-187; 2010.
  • Melatonin as a therapeutic tool in ophthalmology: implication for glaucoma and uveitis. R.E. Rosenstein, S.R. Pandi-Perumal, V. Srinivasan, D.W. Spence, G.M. Brown, D.P. Cardinali. Journal of Pineal Research 49(1):1-13; 2010. (download pdf)
  • Potential use of melatonergic drugs in analgesia: mechanisms of action. V. Srinivasan, S. R. Pandi- Perumal, D. W. Spence, A. Moscovitch, I. Trakht, G. M. Brown, D. P. Cardinali. Brain Research Bulletin, 81 (2010) 362–371. (download pdf)
  • Malaria: Therapeutic implications of melatonin. V. Srinivasan, D. W. Spence, A. Moscovitch, S. R. Pandi- Perumal, I. Trakht, G. M. Brown, D. P. Cardinali. Journal of Pineal Research 48 (1) 1-8; 2010. (download pdf)
  • Melatonin in septic shock: Some recent concepts. V. Srinivasan, S: R. Pandi-Perumal, D. W. Spence, H. Kato, D. P. Cardinali . Journal of Critical Care (2010) 25, 656.e1–656.e6. (download pdf)
  • International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors. M. L. Dubocovich, P. Delagrange, D. N. Krause, D. Sugden, D. P. Cardinali, J. Olcese. Pharmacological Reviews 62(3):343-380; 2010. (download pdf)
  • Potential use of melatonergic drugs in analgesia: mechanisms of action. V. Srinivasan, S. R. Pandi- Perumal, D. W. Spence, A. Moscovitch, I. Trakht, G. M. Brown, D. P. Cardinali. Brain Research Bulletin, 81 (2010) 362–371. (download pdf)